Skip to main content

Antimicrobial Resistance Symposium

Please note that by clicking on a link you will be redirected outside bioMérieux's website.

 

This event was developed and organized by a cross-functional team at bioMérieux Canada and their partners at Emerging & Pandemic Infections Consortium (EPIC) for the World Antimicrobial Awareness Week 2022.

Experts from North America shared their knowledge and experience around Antimicrobial Resistance (AMR) and Antimicrobial Stewardship (AMS). The talks go through Strategies to tackle Antimicrobial Resistance, the value of diagnostics in patient management and implementation of Antimicrobial Stewardship programs, from theory to real-life cases.

Multi-drug resistant organisms in the laboratory -impact and challenges

Multi-drug resistant organisms in the laboratory - impact and challenges

In this talk, Dr. Susan Poutanen speaks about multi-drug resistant organisms (MDROs), and in particular about the challenges labs face when interpreting antibiograms. She explains the impact of MDROs from a lab perspective and discusses the solutions available to fight MDROs, from drugs to phage therapy.

Watch Session
A Pandemic within a pandemic

A Pandemic within a pandemic: antibiotic resistance and COVID-19

Dr. Bradley Langford explains how COVID-19 impacts AMR and highlights the overuse of antibiotics through inappropriate antibiotic prescription.  

Watch Session
Promoting behavioral change: adapting stewardship approaches based in behavioral models

Promoting behavioral change: adapting stewardship approaches based in behavioral models

Dr. Cora Constantinescu outlines the behavioral and social factors that play a role in antimicrobial prescribing decisions. She also explains the importance of having a structured communication framework in clinical interactions. 

Watch Session
An update on AMR situation in Canada in Canadian Hospitals

An update on AMR situation in Canada in Canadian Hospitals

Dr. Charles Frenette gives a hospital point of view of the AMR situation and presents the main trends on MRSA, VRE, CPE and BSI.

Watch Session
One Health and AMR

One Health and AMR

Dr. Jane Parmley talks about AMR through the One Health approach. She goes from the correlation between AMR in food-producing animals and AMR in humans, to the actions required to combat AMR.

Watch Session
Understanding breakpoints

Understanding breakpoints

In this talk, Dr. Tony Mazzulli provides a definition of breakpoints, explains the concept of MIC and discusses the limitations of breakpoints when applied to clinical decision-making.

Watch Session
Why we need a One Health approach to stewardship

Why we need a One Health approach to stewardship

Dr. John Conly highlights the importance of the One Health approach to fight AMR. He speaks about antimicrobial consumption, the impact of COVID-19 and the latest WHO recommendations.

Watch Session
Antimicrobial Stewardship for primary care

Antimicrobial Stewardship for primary care

Dr. Kevin Schwartz talks about the implementation of AMS in primary care settings, focusing on antibiotic consumption and treatment duration.

Watch Session
Gaps in our understanding of AMR – How research can help

Gaps in our understanding of AMR – How research can help

Dr. Susan Poutanen talks about Antimicrobial Stewardship and how research can help fight AMR. 

Watch Session
Research advances in the antimicrobial pipeline – novel phage-based therapeutics

Research advances in the antimicrobial pipeline – novel phage-based therapeutics

Dr. Karen Maxwell defines the mechanisms involved in phage therapy. She speaks about phages as a treatment to fight infection diseases and describes the latest research advances in terms of phage therapy. 

Watch Session
New Antimicrobial pipeline – What’s in development and what’s needed

New Antimicrobial pipeline – What’s in development and what’s needed

In this talk, Dr. George Zhanel reviews the new antimicrobials available in Canada and discusses the pathogens for which new antibiotics are needed.

Watch Session
CRISPR-based point-of-care diagnostics for monitoring resistance

CRISPR-based point-of-care diagnostics for monitoring resistance

Dr. Nikki Weckman talks about CRISPR technique as an early diagnostic development. She covers infection prevention and control, and AMS surveillance with a specific focus on Candida auris infections. 

Watch Session
Role and gaps of current microbiology diagnostics to address sepsis

Role and gaps of current microbiology diagnostics to address sepsis

In this talk, Dr. Katherine Perez focuses on sepsis. She explains the changes in the definition of sepsis and gives an update on the sepsis situation worldwide. She reviews the gaps in current microbiology diagnostics and the rapid diagnostics landscape to address sepsis.

Watch Session

The content on this website and associated materials do not constitute medical advice and should not be considered a substitute for the individual professional judgement of any physician or other health care practitioner regarding the appropriate course of action for a particular patient. All recommendations should be independently reviewed with appropriate medical staff in light of the needs of any particular institution and its patients. bioMérieux makes no guarantee or representation regarding the accuracy, completeness, or usefulness of this information for any particular purpose, including but not limited to any cost savings.